Consumers holding back inflammatory market: NIU poll

By Stephen Daniells

- Last updated on GMT

Related tags: Inflammation, Anti-inflammatory

The main challenge facing the rise of products targeting inflammation is consumers, and their lack of understanding about what inflammation is, according to a NutraIngredients-USA poll.

Last week we asked you, our readers, to decide which challenge was the most significant – science (our understanding of inflammation is not developed enough); consumers (they don’t understand inflammation); marketers (they don’t know how to communicate inflammation); or everything (inflammation will never be a mainstream health category).

As our chart below shows​, of the 101 people who voted, 43.6 percent said that consumers will need educating before the sector can take off, while 30.7 percent think that the science is the rate-limiter for this market. (Articles continues with chart below ↓​)

Our special edition on inflammation​ pooled opinion and insight from a host of industry personalities. We looked at the science behind anti-inflammatory ingredients, consumers’ (lack of) understanding, and the market potential of anti-inflammatory formulations.

Related topics: Markets, Inflammation

Related news

Show more

Related products

show more

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars